Safety and Immunogenicity Among Adults of Fluzone(R), Influenza Virus Vaccines 2012-2013 Formulation (Intradermal and Intramuscular Route)
Phase of Trial: Phase IV
Latest Information Update: 01 Nov 2013
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- Sponsors Sanofi
- 01 Feb 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 28 Sep 2012 New trial record